Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06907199 · ClinicalTrials.gov registry record · Phase 1
Daily Nitrofurantoin Versus Bladder Fulguration Plus Daily Nitrofurantoin for Women With Recurrent Urinary Tract Infections
A Phase 1 study, sponsored by University of Texas Southwestern Medical Center.
- Recruiting
- Registry status
- Phase 1
- Development phase
- 104
- Enrollment target
NCT06907199 is a Phase 1 study that is actively recruiting participants, run by University of Texas Southwestern Medical Center. The registered enrollment target is 104 participants.
The verdict
NCT06907199, a Phase 1 study, is actively recruiting participants, sponsored by University of Texas Southwestern Medical Center.
- RECRUITING
- Registry status
- Phase 1
- Development phase
- 104 participants
- Enrollment target
Study Summary
The goal of this clinical trial is to learn if the drug Nitrofurantoin (NF) taken as a daily antibiotic, works to treat cystitis compared to electrofulguration (EF) and Nitrofurantoin (NF) daily antibiotic.
Interventions
- PROCEDURE Electrofulguration (EF)
- DRUG Nitrofurantoin (NF)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 104 participants |
| Start Date | 2026-04-06 |
| Est. Completion | 2029-01-30 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06907199
The ClinicalTrials.gov registry entry for NCT06907199 describes a study currently listed as recruiting, categorized as Phase 1. The registered enrollment target is 104 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Texas Southwestern Medical Center, which has 837 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Electrofulguration (EF) is the first listed.
NCT06907199 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT06907199 about?
NCT06907199 is a clinical study titled "Daily Nitrofurantoin Versus Bladder Fulguration Plus Daily Nitrofurantoin for Women With Recurrent Urinary Tract Infections". The goal of this clinical trial is to learn if the drug Nitrofurantoin (NF) taken as a daily antibiotic, works to treat cystitis compared to electrofulguration (EF) and Nitrofurantoin (NF) daily antibiotic.
What is the current status of trial NCT06907199?
This trial is currently recruiting. It is a Phase 1 study. The enrollment target is 104 participants. The study started on 2026-04-06. Estimated completion is 2029-01-30.
What interventions are being tested in trial NCT06907199?
The interventions under investigation include: Electrofulguration (EF) (PROCEDURE), Nitrofurantoin (NF) (DRUG).
Who is sponsoring clinical trial NCT06907199?
This trial is sponsored by University of Texas Southwestern Medical Center, which has 837 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.